Cargando…

Oat Bran Increased Fecal Butyrate and Prevented Gastrointestinal Symptoms in Patients With Quiescent Ulcerative Colitis—Randomized Controlled Trial

BACKGROUND: Oat bran specifically increases colon butyrate concentrations and could therefore affect the progress of the disease in patients with ulcerative colitis (UC). METHODS: Patients with UC in remission were enrolled in a controlled multicenter study and randomized to eat oat bran or low-fibe...

Descripción completa

Detalles Bibliográficos
Autores principales: Nyman, Margareta, Nguyen, Thao Duy, Wikman, Ola, Hjortswang, Henrik, Hallert, Claes
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9802401/
https://www.ncbi.nlm.nih.gov/pubmed/36777965
http://dx.doi.org/10.1093/crocol/otaa005
_version_ 1784861674042294272
author Nyman, Margareta
Nguyen, Thao Duy
Wikman, Ola
Hjortswang, Henrik
Hallert, Claes
author_facet Nyman, Margareta
Nguyen, Thao Duy
Wikman, Ola
Hjortswang, Henrik
Hallert, Claes
author_sort Nyman, Margareta
collection PubMed
description BACKGROUND: Oat bran specifically increases colon butyrate concentrations and could therefore affect the progress of the disease in patients with ulcerative colitis (UC). METHODS: Patients with UC in remission were enrolled in a controlled multicenter study and randomized to eat oat bran or low-fiber wheat products. RESULTS: Ninety-four of the enrolled patients (n = 47 for both groups) completed the 24-week study. The oat bran group had significantly (P < 0.05) higher fecal butyrate concentrations and lower serum LDL levels, while deterioration of gastrointestinal symptoms was prevented, and subjective health maintained. The control diet significantly (P < 0.05) increased obstipation, reflux, and the symptom burden and had no effects on butyrate or LDL-cholesterol. The relapse rate was the same for both diets. CONCLUSIONS: Oat bran was well tolerated when given to patients with quiescent UC.
format Online
Article
Text
id pubmed-9802401
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-98024012023-02-10 Oat Bran Increased Fecal Butyrate and Prevented Gastrointestinal Symptoms in Patients With Quiescent Ulcerative Colitis—Randomized Controlled Trial Nyman, Margareta Nguyen, Thao Duy Wikman, Ola Hjortswang, Henrik Hallert, Claes Crohns Colitis 360 Observations and Research BACKGROUND: Oat bran specifically increases colon butyrate concentrations and could therefore affect the progress of the disease in patients with ulcerative colitis (UC). METHODS: Patients with UC in remission were enrolled in a controlled multicenter study and randomized to eat oat bran or low-fiber wheat products. RESULTS: Ninety-four of the enrolled patients (n = 47 for both groups) completed the 24-week study. The oat bran group had significantly (P < 0.05) higher fecal butyrate concentrations and lower serum LDL levels, while deterioration of gastrointestinal symptoms was prevented, and subjective health maintained. The control diet significantly (P < 0.05) increased obstipation, reflux, and the symptom burden and had no effects on butyrate or LDL-cholesterol. The relapse rate was the same for both diets. CONCLUSIONS: Oat bran was well tolerated when given to patients with quiescent UC. Oxford University Press 2020-02-13 /pmc/articles/PMC9802401/ /pubmed/36777965 http://dx.doi.org/10.1093/crocol/otaa005 Text en © 2020 Crohn’s & Colitis Foundation. Published by Oxford University Press on behalf of Crohn's & Colitis Foundation. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Observations and Research
Nyman, Margareta
Nguyen, Thao Duy
Wikman, Ola
Hjortswang, Henrik
Hallert, Claes
Oat Bran Increased Fecal Butyrate and Prevented Gastrointestinal Symptoms in Patients With Quiescent Ulcerative Colitis—Randomized Controlled Trial
title Oat Bran Increased Fecal Butyrate and Prevented Gastrointestinal Symptoms in Patients With Quiescent Ulcerative Colitis—Randomized Controlled Trial
title_full Oat Bran Increased Fecal Butyrate and Prevented Gastrointestinal Symptoms in Patients With Quiescent Ulcerative Colitis—Randomized Controlled Trial
title_fullStr Oat Bran Increased Fecal Butyrate and Prevented Gastrointestinal Symptoms in Patients With Quiescent Ulcerative Colitis—Randomized Controlled Trial
title_full_unstemmed Oat Bran Increased Fecal Butyrate and Prevented Gastrointestinal Symptoms in Patients With Quiescent Ulcerative Colitis—Randomized Controlled Trial
title_short Oat Bran Increased Fecal Butyrate and Prevented Gastrointestinal Symptoms in Patients With Quiescent Ulcerative Colitis—Randomized Controlled Trial
title_sort oat bran increased fecal butyrate and prevented gastrointestinal symptoms in patients with quiescent ulcerative colitis—randomized controlled trial
topic Observations and Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9802401/
https://www.ncbi.nlm.nih.gov/pubmed/36777965
http://dx.doi.org/10.1093/crocol/otaa005
work_keys_str_mv AT nymanmargareta oatbranincreasedfecalbutyrateandpreventedgastrointestinalsymptomsinpatientswithquiescentulcerativecolitisrandomizedcontrolledtrial
AT nguyenthaoduy oatbranincreasedfecalbutyrateandpreventedgastrointestinalsymptomsinpatientswithquiescentulcerativecolitisrandomizedcontrolledtrial
AT wikmanola oatbranincreasedfecalbutyrateandpreventedgastrointestinalsymptomsinpatientswithquiescentulcerativecolitisrandomizedcontrolledtrial
AT hjortswanghenrik oatbranincreasedfecalbutyrateandpreventedgastrointestinalsymptomsinpatientswithquiescentulcerativecolitisrandomizedcontrolledtrial
AT hallertclaes oatbranincreasedfecalbutyrateandpreventedgastrointestinalsymptomsinpatientswithquiescentulcerativecolitisrandomizedcontrolledtrial